Mike Mulroy

Insider profile

Currently holds positions in Mallinckrodt Ard Inc, Lineage Cell Therapeutics Inc and Asterias Biotherapeutics Inc

Performance

Overall performance
2.5
Performance over holding periods
2.5
30 days 90 days 120 days
Average return -4% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Executive Vice President - Strategic Affairs, General Counsel Mallinckrodt Ard Inc Feb. 17, 2014 -
Independent Director Lineage Cell Therapeutics Inc Oct. 4, 2014 -
President, Chief Executive Officer Asterias Biotherapeutics Inc March 8, 2019 -
President, Chief Executive Officer, Director Asterias Biotherapeutics Inc June 26, 2017 - March 8, 2019
Independent Director Comarco Inc Jan. 1, 2011 - Aug. 25, 2014
Chief Financial Officer, Executive Vice President, General Counsel, Corporate Secretary Mallinckrodt Ard Inc July 31, 2013 - Feb. 17, 2014
Chief Financial Officer, Senior Vice President, General Counsel, Corporate Secretary Mallinckrodt Ard Inc Jan. 10, 2011 - July 31, 2013
Mike Mulroy's trades of Lineage Cell Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
25.11
Quantity 84,420 +14.4%
Value US$4,996,442
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-25 2024-11-22
B Purchase
84,420 +14.4%
25.11
US$4,996,442 		84,420 +14.4% 25.11 US$4,996,442
2022-03-25 2022-03-24
B Purchase
25,139 -25.9%
181.89
US$2,777,531 		25,139 -25.9% 181.89 US$2,777,531